Analysis of import and export of traditional Chinese medicine in the first three quarters of 2009

According to customs statistics, the import and export volume of traditional Chinese medicine in the first three quarters of this year reached US $1.43 billion, a record high, up 10.7% year on year Among them, the import value was US $390 million, up 18.5% year on year; the export value was US $1.04 billion, up 8.1% year on year From January to September, the top five Chinese medicine export markets by value are: Japan, Hong Kong, the United States, Vietnam and Malaysia Exports to Japan and Hong Kong accounted for us $200 million and US $150 million, respectively, accounting for 19% and 14% of China's exports of traditional Chinese medicine; exports to Malaysia, the United States and Vietnam grew rapidly; South Korea's exports to South Korea declined significantly due to the establishment of technical barriers to trade The top five import markets are Hong Kong, the United States, India, Germany and Japan In addition to the Chinese patent medicines imported from Hong Kong, most of the products imported from other countries are plant extracts and essential oils, while most of the products imported from Latin American countries are seaweed, algae, fish oil and fat separation products In the first three quarters, the cumulative import and export volume of Chinese herbal medicines and pieces of decoction was 189000 tons, down 5% year on year; the import and export volume was 440 million US dollars, down 1.7% year on year Among them, the export volume was 156000 tons, down 3.7% year on year; the export volume was 370 million US dollars, down 4% year on year The import volume is 34000 tons, down 10.8% year on year; the import volume is 67.53 million US dollars, up 13% year on year From January to September, the main export markets of Chinese herbal medicines and pieces were ranked as Hong Kong, Japan, Vietnam, South Korea and Taiwan But demand in Latin America is growing strongly, while exports to Europe are falling more Guangdong and Guangxi are the main export provinces of traditional Chinese medicine From January to September, the export growth rate of Hubei Province and Sichuan Province was larger, while that of Beijing, Zhejiang Province and Jilin Province was larger From January to September, there were 960 enterprises exporting Chinese herbal medicines and pieces, 13 fewer than the same period last year, including 652 private enterprises, accounting for 68% of all export enterprises From January to September, there were five enterprises with export value of more than 10 million US dollars The top export enterprises of traditional Chinese medicine and pieces of decoction are Guangxi Ningming import and Export Trade Corporation, Tibet Tangfan Industry Co., Ltd., China Medical and Health Products Co., Ltd and Sichuan Chuancun traditional Chinese Medicine Co., Ltd.; the export growth rate is faster in Anhui boguang Medicine Co., Ltd and sichuanchuan village traditional Chinese Medicine Co., Ltd In the first three quarters, the export growth of plant extracts was strong, and it was the only one with a significant year-on-year increase in the export of traditional Chinese medicine This year, the export volume of plant extracts has been the first place in the export volume of various commodities of traditional Chinese medicine, and the proportion has gradually increased, accounting for 46.5% of the total export volume of traditional Chinese medicine commodities, which has become the main driving force to promote the export of traditional Chinese medicine commodities From January to September, the total import and export volume of plant extracts reached 35000 tons, up 21% year on year; the total import and export volume was 596 million US dollars, up 36% year on year Among them, the export volume is 26000 tons, up 9.6% year on year; the export volume is 480 million US dollars, up 25.5% year on year From the perspective of export product structure, the largest increase in export amount is natural pigment products In terms of single variety, the export amount of stevioside increased significantly; the price of high-purity plant extracts increased significantly year-on-year, but the export amount decreased significantly year-on-year; the export amount and export amount of low-purity plant extracts increased slightly From January to September, the main export markets of China's extracts were Japan and the United States, and the export growth markets were India and Malaysia The main export provinces of plant extracts are Shandong, Zhejiang and Shanghai The export growth is faster in Shandong, Jiangsu and Yunnan, and the average export price of Guangdong is growing faster Foreign and private enterprises are the main force of extractive export, and the export growth of foreign enterprises is up to 41% year on year From January to September, 984 enterprises exported extracts, an increase of 91 over the same period of last year, including 10 enterprises with an export value of more than US $10 million The top export enterprises are Hebei Chenguang Natural Pigment Co., Ltd., Ganzhou Julong high tech Food Co., Ltd., Ningbo lvzhijian Pharmaceutical Co., Ltd., Shanghai Jincun Pharmaceutical Co., Ltd and Qingdao Runde Biotechnology Co., Ltd The export growth of Qingdao Runde Biotechnology Co., Ltd., Ganzhou Julong high tech Food Co., Ltd and Zibo Qianqian International Trade Co., Ltd is fast In the first three quarters, the import and export volume of Chinese patent medicine shrank at the same time The import and export volume of Chinese patent medicine reached 246 million US dollars, down 6.4% year on year The import and export volume of Chinese patent medicine accounted for 17.15% of the import and export volume of traditional Chinese medicine products Imports of Chinese patent medicine reached 126 million US dollars, down 8% year on year; exports reached 120 million US dollars, down 4.6% year on year From January to September, China exported Chinese patent medicines to 120 countries, and the main export market is still the traditional market Hong Kong, Japan and the United States The main export areas of Chinese patent medicine are Guangdong, Beijing, Fujian and Tianjin, and the export growth of Hainan and Hebei is relatively fast State owned enterprises are the main body of the export of Chinese patent medicine, accounting for about 58% of the total export of Chinese patent medicine, and the export of foreign-funded enterprises has declined significantly From January to September, 526 enterprises exported proprietary Chinese medicines, a year-on-year decrease of 53, of which only two enterprises exported more than $5 million From January to September, the three largest export enterprises are Beijing Tongrentang Co., Ltd., Zhangzhou Pianzihuang Pharmaceutical Co., Ltd and Guangzhou Pharmaceutical Import and export company The export growth of liangjiefu (Guangdong) Pharmaceutical Co., Ltd and Shandong dong'a Rubber Co., Ltd The export of health care products was stable In the first three quarters, the import and export volume of health care products in China was 150 million US dollars, up 3.74% year on year Among them, the export volume was US $63.41 million, up 1.2% year on year; the import volume was US $86.99 million, up 5.7% year on year From January to September, the main export markets of China's health products are still Japan and the United States, accounting for about 62.5% of China's health products exports The import of health care products from the United States, Canada and Germany increased rapidly Zhejiang and Guangdong are the major export provinces of health products in China, and Guangdong and Shandong are the fastest growing export provinces Three foreign-funded and private enterprises are the main force in the export of health care products, accounting for about 85% of domestic and foreign exports From January to September, Guangdong xianle Pharmaceutical Co., Ltd., Shandong Yuwang Pharmaceutical Co., Ltd., Jiangsu Aoqi marine Bioengineering Co., Ltd and Qinghai Xinkai Industrial Co., Ltd were the enterprises that exported more health care products; Shanghai Weihang Biotechnology Co., Ltd and Shandong Yuwang Pharmaceutical Co., Ltd grew faster in export.